Summation Bio, Inc.
About
What does Summation Bio, Inc. do?
Summation Bio, Inc. is a biotechnology company dedicated to advancing the treatment of complex diseases. They leverage cutting-edge scientific approaches to discover and develop innovative therapeutic candidates, aiming to address unmet medical needs.
What is Summation Bio, Inc.'s revenue?
StartupHub estimates Summation Bio, Inc.'s annual revenue at $3.3M (range $691K to $11.0M, 29% confidence), based on comparable companies in the sector.
What is Summation Bio, Inc.'s valuation?
StartupHub estimates Summation Bio, Inc.'s effective valuation at $36.7M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Summation Bio, Inc. raised?
Summation Bio, Inc. has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Summation Bio, Inc. headquartered?
Summation Bio, Inc. is headquartered in Cambridge, United States.
When was Summation Bio, Inc. founded?
Summation Bio, Inc. was founded in 2021.
What industry does Summation Bio, Inc. operate in?
Summation Bio, Inc. operates in Biotech, Drug Discovery, Genomics, HealthTech, AI-Driven Protein Design.
What is Summation Bio, Inc.'s current status?
Summation Bio, Inc.'s current operating status is: Inactive.
No comments yet. Be the first to share your take.